| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $306,992 ) |
| | 2025 | 2025 | CUBIT DIAGNOSTICS, INC | 2270 Camino Vida Roble Ste J | Carlsbad | CA | 92011-1503 | SAN DIEGO | USA | R43PS005313 | Development of an ultrasensitive, rapid and portable nucleic acid based test for detection of acute Hepatitis C Virus infection at the point-of-care. | 00 | 1 | CDC | 9/12/2025 | $6,352 |
| | 2025 | 2025 | CUBIT DIAGNOSTICS, INC | 2270 Camino Vida Roble Ste J | Carlsbad | CA | 92011-1503 | SAN DIEGO | USA | R43PS005313 | Development of an ultrasensitive, rapid and portable nucleic acid based test for detection of acute Hepatitis C Virus infection at the point-of-care. | 00 | 1 | CDC | 9/12/2025 | $82,703 |
| | 2025 | 2025 | CUBIT DIAGNOSTICS, INC | 2270 Camino Vida Roble Ste J | Carlsbad | CA | 92011-1503 | SAN DIEGO | USA | R43PS005313 | Development of an ultrasensitive, rapid and portable nucleic acid based test for detection of acute Hepatitis C Virus infection at the point-of-care. | 00 | 1 | CDC | 9/12/2025 | $151,796 |
| | 2025 | 2025 | CUBIT DIAGNOSTICS, INC | 2270 Camino Vida Roble Ste J | Carlsbad | CA | 92011-1503 | SAN DIEGO | USA | R43PS005313 | Development of an ultrasensitive, rapid and portable nucleic acid based test for detection of acute Hepatitis C Virus infection at the point-of-care. | 00 | 1 | CDC | 9/12/2025 | $66,141 |
|
|
